Literature DB >> 23150694

Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study.

Marco Medici1, Sarah Timmermans, Willy Visser, Sabine M P F de Muinck Keizer-Schrama, Vincent W W Jaddoe, Albert Hofman, Herbert Hooijkaas, Yolanda B de Rijke, Henning Tiemeier, Jacoba J Bongers-Schokking, Theo J Visser, Robin P Peeters, Eric A P Steegers.   

Abstract

CONTEXT: Maternal hyperthyroidism during pregnancy is associated with an increased risk of low birth weight, predisposing to neonatal morbidity and mortality. However, the effects of variation in maternal serum thyroid parameters within the normal range on birth weight are largely unknown.
OBJECTIVE: The aim was to study the effects of early pregnancy maternal serum thyroid parameters within the normal range on birth weight, as well as the relation between umbilical cord thyroid parameters and birth weight. DESIGN, SETTING, AND PARTICIPANTS: In early pregnancy, serum TSH, FT4 (free T(4)), and thyroid peroxidase antibody levels were determined in 4464 pregnant women. Cord serum TSH and FT4 levels were determined in 2724 newborns. Small size for gestational age at birth (SGA) was defined as a gestational age-adjusted birth weight below the 2.5th percentile. The associations between normal-range maternal and cord thyroid parameters, birth weight, and SGA were studied using regression analyses.
RESULTS: In mothers with normal-range FT4 and TSH levels, higher maternal FT4 levels were associated with lower birth weight [β = -15.4 (3.6) g/pmol · liter, mean (SE); P = 1.6 × 10(-5)], as well as with an increased risk of SGA newborns [odds ratio (95% confidence interval) = 1.09 (1.01-1.17); P = 0.03]. Birth weight was positively associated with both cord TSH [β = 4.1 (1.4) g/mU · liter; P = 0.007] and FT4 levels [β = 23.0 (3.2) g/pmol · liter; P = 9.2 × 10(-13)].
CONCLUSIONS: We show that maternal high-normal FT4 levels in early pregnancy are associated with lower birth weight and an increased risk of SGA newborns. Additionally, birth weight is positively associated with cord TSH and FT4 levels. These data demonstrate that even mild variation in thyroid function within the normal range can have important fetal consequences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23150694     DOI: 10.1210/jc.2012-2420

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

Review 1.  Thyroid disease in pregnancy: new insights in diagnosis and clinical management.

Authors:  Tim I M Korevaar; Marco Medici; Theo J Visser; Robin P Peeters
Journal:  Nat Rev Endocrinol       Date:  2017-08-04       Impact factor: 43.330

2.  The Generation R Study: Biobank update 2015.

Authors:  Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

3.  Is there enough evidence of poor fetal growth to merit narrowing free T4 reference ranges during pregnancy?

Authors:  Tuija Männistö
Journal:  J Clin Endocrinol Metab       Date:  2013-01       Impact factor: 5.958

4.  Urinary phthalate metabolite and bisphenol A associations with ultrasound and delivery indices of fetal growth.

Authors:  Kelly K Ferguson; John D Meeker; David E Cantonwine; Yin-Hsiu Chen; Bhramar Mukherjee; Thomas F McElrath
Journal:  Environ Int       Date:  2016-06-16       Impact factor: 9.621

5.  Implications of High Free Thyroxine (FT4) concentrations in euthyroid pregnancies: the FaSTER trial.

Authors:  James E Haddow; Wendy Y Craig; Louis M Neveux; Hamish R M Haddow; Glenn E Palomaki; Geralyn Lambert-Messerlian; Fergal D Malone; Mary E D'Alton
Journal:  J Clin Endocrinol Metab       Date:  2014-02-28       Impact factor: 5.958

6.  Subclinical Changes in Maternal Thyroid Function Parameters in Pregnancy and Fetal Growth.

Authors:  Lauren E Johns; Kelly K Ferguson; David E Cantonwine; Bhramar Mukherjee; John D Meeker; Thomas F McElrath
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

7.  Excess Maternal Thyroxine Alters the Proliferative Activity and Angiogenic Profile of Growth Cartilage of Rats at Birth and Weaning.

Authors:  Lorena Gabriela Rocha Ribeiro; Juneo Freitas Silva; Natália de Melo Ocarino; Cíntia Almeida de Souza; Eliane Gonçalves de Melo; Rogéria Serakides
Journal:  Cartilage       Date:  2016-12-28       Impact factor: 4.634

8.  Maternal urinary phthalate metabolites during pregnancy and thyroid hormone concentrations in maternal and cord sera: The HOME Study.

Authors:  Megan E Romano; Melissa N Eliot; R Thomas Zoeller; Andrew N Hoofnagle; Antonia M Calafat; Margaret R Karagas; Kimberly Yolton; Aimin Chen; Bruce P Lanphear; Joseph M Braun
Journal:  Int J Hyg Environ Health       Date:  2018-03-23       Impact factor: 5.840

9.  Maternal, cord, and three-year-old child serum thyroid hormone concentrations in the Health Outcomes and Measures of the Environment study.

Authors:  Brett T Doherty; Noelle Kosarek; Andy N Hoofnagle; Yingying Xu; R Thomas Zoeller; Kimberly Yolton; Aimin Chen; Bruce P Lanphear; Joseph M Braun; Megan E Romano
Journal:  Clin Endocrinol (Oxf)       Date:  2020-01-19       Impact factor: 3.478

10.  Thyroid Hormone Status in Umbilical Cord Serum Is Positively Associated with Male Anogenital Distance.

Authors:  Rongju Liu; Xijin Xu; Yuling Zhang; Xiangbin Zheng; Stephani S Kim; Kim N Dietrich; Shuk-Mei Ho; Tiina Reponen; Aimin Chen; Xia Huo
Journal:  J Clin Endocrinol Metab       Date:  2016-07-06       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.